Skip to main content
FinSpry Logo
FinSpry
AVDL logo
AVDL
(NASDAQ)
Avadel Pharmaceuticals plc
$21.64-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Avadel Pharmaceuticals (AVDL) Stock Price & Financial Analysis

Avadel Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.64 - $21.64
52-Week High$23.57
52-Week Low$6.38
Open$21.64
Market Cap2.19B
Shares Outstanding101.28M
Price to Sales (P/S)8.82
Price to Book (P/B)22.31
EV/EBITDA208.72
Revenue (TTM)248.52M
Net Income (TTM)-278.00K
Free Cash Flow (TTM)19.35M
EPS (TTM)$0.00
Profit Margin-0.11%
Operating Margin1.82%
Return on Equity (ROE)-0.28%
Debt to Equity0.03
50-Day MA$21.51
200-Day MA$15.56
52-Week Change140.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Avadel Pharmaceuticals

What is the current stock price for AVDL?

As of the latest trading session, AVDL stock trades at $21.64. The 52-week range is $6.38–$23.57, with a day range of $21.64–$21.64.

What is the P/E ratio for AVDL?

The P/E ratio (Price-to-Earnings) for AVDL is shown in the Key Statistics section. This valuation metric helps compare Avadel Pharmaceuticals plc to industry peers.

Does AVDL pay dividends?

Avadel Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AVDL?

Analyst ratings and recommendations for AVDL are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of AVDL?

Avadel Pharmaceuticals's market capitalization is $2.19B, classifying it as a mid-cap company. Avadel Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.